Imetit dihydrobromide is primarily used in pharmacological research as a selective agonist for the histamine H3 receptor. It plays a crucial role in studying the function and modulation of this receptor, which is involved in various neurological and cognitive processes. Researchers utilize it to explore potential treatments for disorders such as narcolepsy, attention deficit hyperactivity disorder (ADHD), and Alzheimer's disease, as H3 receptors are known to regulate neurotransmitter release in the brain. Additionally, it aids in understanding the role of histamine in sleep-wake cycles, appetite regulation, and learning and memory mechanisms. Its application extends to preclinical studies aimed at developing new therapeutic agents targeting the central nervous system.